Multiday Fully Closed Loop Insulin Delivery in Monitored Outpatient Conditions

NCT02127827 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

30

Enrollment

OTHER_GOV

Sponsor class

Conditions

To Demonstrate That the Closed Loop System Can be Used Safely Over a Few Consecutive Days.
To Assess Effectiveness in Maintaining Patients' Glucose Levels in the Target Range of 70 to 180 mg/dl, Measured by Blood Glucose Sensor.
To Evaluate the User Experience With a Closed Loop System

Interventions

DEVICE: Automated Ambulatory Glycemic Controller (AAGC)

Sponsor

Sheba Medical Center